Cyclosporin A inhibits positive selection and delays negative selection in αβ TCR transgenic mice

Kevin B. Urdahl, Andrew Mark Pardoll, Marc K. Jenkins

Research output: Contribution to journalArticle

Abstract

Cyclosporin A (CsA) is an immunosuppressive drug that inhibits TCR- mediated signal transduction. This drug has two major effects on developing αβ thymocytes in normal mice: it blocks the development of most mature CD4+8- and CD4-8+ thymocytes and inhibits the deletion of some but not all self-specific thymocytes. The latter effect may explain how CsA treatment can paradoxically induce autoimmunity in certain situations. Here we investigated the effects of CsA on thymocyte development in transgenic mice that express on most of their T cells an αβ TCR specific for male H-Y Ag bound to H-2 Db class I molecules, a model system in which positive and negative selection have been clearly defined. Positive selection occurs in female mice, resulting in the development of mature CD4-CD8+ T cells, whereas negative selection occurs in male mice, resulting in the deletion of self-reactive CD4+8+ thymocytes. CsA blocked positive selection, as evidenced by the finding that most of the cells present in the thymuses of CsA-treated female mice were functionally immature precursors that expressed heat-stable Ag. In male mice, CsA delayed but did not prevent the deletion of most CD4+8+ thymocytes. A few transgenic thymocytes, however, were not deleted and achieved the TCR+, CD4-8+ phenotype of positively selected cells. Therefore, for a small subset of thymocytes, CsA may convert a normally negatively selecting TCR signal to a positively selecting one.

Original languageEnglish (US)
Pages (from-to)2853-2859
Number of pages7
JournalJournal of Immunology
Volume152
Issue number6
StatePublished - Mar 15 1994

Fingerprint

Thymocytes
Transgenic Mice
Cyclosporine
T-Lymphocytes
Immunosuppressive Agents
Autoimmunity
Pharmaceutical Preparations
Thymus Gland
Signal Transduction
Hot Temperature
Phenotype

ASJC Scopus subject areas

  • Immunology

Cite this

Cyclosporin A inhibits positive selection and delays negative selection in αβ TCR transgenic mice. / Urdahl, Kevin B.; Pardoll, Andrew Mark; Jenkins, Marc K.

In: Journal of Immunology, Vol. 152, No. 6, 15.03.1994, p. 2853-2859.

Research output: Contribution to journalArticle

@article{2dfb8e79673647428826c77d1d899179,
title = "Cyclosporin A inhibits positive selection and delays negative selection in αβ TCR transgenic mice",
abstract = "Cyclosporin A (CsA) is an immunosuppressive drug that inhibits TCR- mediated signal transduction. This drug has two major effects on developing αβ thymocytes in normal mice: it blocks the development of most mature CD4+8- and CD4-8+ thymocytes and inhibits the deletion of some but not all self-specific thymocytes. The latter effect may explain how CsA treatment can paradoxically induce autoimmunity in certain situations. Here we investigated the effects of CsA on thymocyte development in transgenic mice that express on most of their T cells an αβ TCR specific for male H-Y Ag bound to H-2 Db class I molecules, a model system in which positive and negative selection have been clearly defined. Positive selection occurs in female mice, resulting in the development of mature CD4-CD8+ T cells, whereas negative selection occurs in male mice, resulting in the deletion of self-reactive CD4+8+ thymocytes. CsA blocked positive selection, as evidenced by the finding that most of the cells present in the thymuses of CsA-treated female mice were functionally immature precursors that expressed heat-stable Ag. In male mice, CsA delayed but did not prevent the deletion of most CD4+8+ thymocytes. A few transgenic thymocytes, however, were not deleted and achieved the TCR+, CD4-8+ phenotype of positively selected cells. Therefore, for a small subset of thymocytes, CsA may convert a normally negatively selecting TCR signal to a positively selecting one.",
author = "Urdahl, {Kevin B.} and Pardoll, {Andrew Mark} and Jenkins, {Marc K.}",
year = "1994",
month = "3",
day = "15",
language = "English (US)",
volume = "152",
pages = "2853--2859",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "6",

}

TY - JOUR

T1 - Cyclosporin A inhibits positive selection and delays negative selection in αβ TCR transgenic mice

AU - Urdahl, Kevin B.

AU - Pardoll, Andrew Mark

AU - Jenkins, Marc K.

PY - 1994/3/15

Y1 - 1994/3/15

N2 - Cyclosporin A (CsA) is an immunosuppressive drug that inhibits TCR- mediated signal transduction. This drug has two major effects on developing αβ thymocytes in normal mice: it blocks the development of most mature CD4+8- and CD4-8+ thymocytes and inhibits the deletion of some but not all self-specific thymocytes. The latter effect may explain how CsA treatment can paradoxically induce autoimmunity in certain situations. Here we investigated the effects of CsA on thymocyte development in transgenic mice that express on most of their T cells an αβ TCR specific for male H-Y Ag bound to H-2 Db class I molecules, a model system in which positive and negative selection have been clearly defined. Positive selection occurs in female mice, resulting in the development of mature CD4-CD8+ T cells, whereas negative selection occurs in male mice, resulting in the deletion of self-reactive CD4+8+ thymocytes. CsA blocked positive selection, as evidenced by the finding that most of the cells present in the thymuses of CsA-treated female mice were functionally immature precursors that expressed heat-stable Ag. In male mice, CsA delayed but did not prevent the deletion of most CD4+8+ thymocytes. A few transgenic thymocytes, however, were not deleted and achieved the TCR+, CD4-8+ phenotype of positively selected cells. Therefore, for a small subset of thymocytes, CsA may convert a normally negatively selecting TCR signal to a positively selecting one.

AB - Cyclosporin A (CsA) is an immunosuppressive drug that inhibits TCR- mediated signal transduction. This drug has two major effects on developing αβ thymocytes in normal mice: it blocks the development of most mature CD4+8- and CD4-8+ thymocytes and inhibits the deletion of some but not all self-specific thymocytes. The latter effect may explain how CsA treatment can paradoxically induce autoimmunity in certain situations. Here we investigated the effects of CsA on thymocyte development in transgenic mice that express on most of their T cells an αβ TCR specific for male H-Y Ag bound to H-2 Db class I molecules, a model system in which positive and negative selection have been clearly defined. Positive selection occurs in female mice, resulting in the development of mature CD4-CD8+ T cells, whereas negative selection occurs in male mice, resulting in the deletion of self-reactive CD4+8+ thymocytes. CsA blocked positive selection, as evidenced by the finding that most of the cells present in the thymuses of CsA-treated female mice were functionally immature precursors that expressed heat-stable Ag. In male mice, CsA delayed but did not prevent the deletion of most CD4+8+ thymocytes. A few transgenic thymocytes, however, were not deleted and achieved the TCR+, CD4-8+ phenotype of positively selected cells. Therefore, for a small subset of thymocytes, CsA may convert a normally negatively selecting TCR signal to a positively selecting one.

UR - http://www.scopus.com/inward/record.url?scp=0028297669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028297669&partnerID=8YFLogxK

M3 - Article

C2 - 8144886

AN - SCOPUS:0028297669

VL - 152

SP - 2853

EP - 2859

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 6

ER -